Filing search / Alkermes plc / "Safety" / Page 2

8-K

EX-99.1

zipkdxkk3dl dh9kqy

25 Oct 23

Alkermes plc Reports Third Quarter 2023 Financial Results

7:06am

8-K

EX-99.2

n9nficvwfn7a

25 Oct 23

Alkermes plc Reports Third Quarter 2023 Financial Results

7:06am

8-K

EX-99.1

s67xfpo12fnfdy3769q

23 Oct 23

Alkermes Presents First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep Congress

8:27am

8-K

EX-99.2

27x8i2wg2p8vbaa

23 Oct 23

Alkermes Presents First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep Congress

8:27am

DEFA14A

3vcc rk5ydfx

7 Jun 23

Additional proxy soliciting materials

5:28pm

DEFA14A

vwmnw

25 May 23

Additional proxy soliciting materials

4:31pm

DEFC14A

v86knj4nl4tn4u1pdj

25 May 23

Proxy in contested solicitation

4:03pm

PRER14A

306bq2618nduh6 7jyx

19 May 23

Preliminary revised proxy

5:23pm

PREC14A

2g97udum0l91o4sw

8 May 23

Preliminary proxy with contested solicitation

4:34pm

8-K

EX-99.2

vu7g3

26 Apr 23

Alkermes plc Reports First Quarter 2023 Financial Results

7:05am